High-dose thiamine supplementation improves glucose tolerance in hyperglycemic individuals: A randomized, double-blind cross-over trial

European Journal of Nutrition

Volumn 52, Issue 7, 2013, Pages 1821-1824

  Alaei Shahmiri, F ^a,b   Soares, M J ^a   Zhao, Y ^a   Sherriff, J ^a  

^a CURTIN UNIVERSITY   (Australia)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular disease; Glucose tolerance; Hyperglycemia; Insulin resistance; Thiamine; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; PLACEBO; THIAMINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEMOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FASTING; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; THIAMINE;

EID: 84885479125     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0534-6     Document Type: Article

References (9)

1. Thornalley P (2005) The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev 1(3):287-298
2. Hassan R, Qureshi H, Zuberi SJ (1991) Effect of thiamine on glucose utilization in hepatic cirrhosis. J Gastroenterol Hepatol 6(1):59-60
3. Bakker SJ, Hoogeveen EK, Nijpels G, Kostense PJ, Dekker JM, Gans RO, Heine RJ (1998) The association of dietary fibres with glucose tolerance is partly explained by concomitant intake of thiamine: the Hoorn Study. Diabetologia 41(10):1168-1175
4. Batty G, Kivimäki M, Davey Smith G, Marmot M, Shipley M (2008) Post-challenge blood glucose concentration and stroke mortality rates in non-diabetic men in London: 38-year follow-up of the original Whitehall prospective cohort study. Diabetologia 51(7):1123-1126
5. Oishi K, Hofmann S, Diaz GA, Brown T, Manwani D, Ng L, Young R, Vlassara H, Ioannou YA, Forrest D, Gelb BD (2002) Targeted disruption of Slc19a2, the gene encoding the high-Affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice. Hum Mol Genet 11(23): 2951-2960
6. Babaei-Jadidi R, Karachalias N, Kupich C, Ahmed N, Thornalley PJ (2004) High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia 47(12):2235-2246. doi:10.1007/s00125-004-1582-5
7. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326(1):22-29. doi:10.1056/NEJM199201023260104
8. Gonzalez-Ortiz M, Martinez-Abundis E, Robles-Cervantes JA, Ramirez-Ramirez V, Ramos-Zavala MG (2011) Effect of thiamine administration on metabolic profile, cytokines and inflammatory markers in drug-naive patients with type 2 diabetes. Eur J Nutr 50(2):145-149. doi:10.1007/s00394-010-0123-x
9. Rabbani N, Alam SS, Riaz S, Larkin JR, Akhtar MW, Shafi T, Thornalley PJ (2009) High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia 52(2):208-212. doi: 10.1007/s00125-008-1224-4